Modifying psychologicAl Treatment to the CHaracteristics and needs of cancer survivors.
Recruiting
- Conditions
- Psychological symptoms, cancer-related fatigue, personalized treatment, ecological momentary assessment (EMA), cancer survivors.Psychische klachten, vermoeidheid bij patiënten met kanker, gepersonaliseerde behandeling, EMA-metingen, overlevenden na kanker.
- Registration Number
- NL-OMON22291
- Lead Sponsor
- Amsterdam UMC, location AMC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 190
Inclusion Criteria
Be ≥ 18 years old
-Be able to speak and read Dutch
Exclusion Criteria
-Insufficient command of the Dutch language
-Currently receiving psychological or psychiatric treatment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient functioning
- Secondary Outcome Measures
Name Time Method -Symptom level<br /><br>oFatigue<br /><br>oDepressive symptoms<br /><br>oFear of cancer recurrence<br /><br>-Quality of life<br /><br>-Goal attainment<br /><br>-Number of therapy sessions<br /><br>-Therapist time per patient<br /><br>-Dropout rate
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie cancer-related fatigue in survivors and how does personalized psychological treatment modulate these pathways?
How does ecological momentary assessment (EMA) enhance the effectiveness of psychological interventions compared to standard care in cancer survivors?
Are there specific biomarkers that predict response to personalized psychological treatment in patients with cancer-related fatigue and psychological symptoms?
What are the potential adverse events associated with EMA-based personalized psychological interventions and how can they be managed?
What combination approaches or competitor drugs are being explored alongside psychological treatments for cancer-related fatigue and psychological symptoms?